In clinical practice, they do not cause weight gain and are weight neutral, with a very low incidence of hypoglycemia as a side effect
Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged
These are not the same as GLP-1 receptor agonists used in medications like Wegovy or Mounjaro and have no equivalent clinical evidence for significant weight loss
Designed for convenient daily use, these fast-absorbing oral drops support appetite regulation, satiety, and healthy metabolic function without the need for injections.* GLP-1/GIP therapy works by supporting pathways involved in appetite control, digestion, insulin response, and energy balance
Injecting too deeply (into muscle) can cause pain, bruising, and altered absorption, whilst too shallow an injection may cause medication leakage or skin irritation
Although a few states do have rules on appropriate practice for weight loss treatments, for the most part, states do not have special rules on policies and procedures for specific medications (controlled substances being the major exception)